41. RTID-05. INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF VORASIDENIB (AG-881) VS PLACEBO IN PATIENTS WITH RESIDUAL/RECURRENT GRADE II GLIOMA WITH AN ISOCITRATE DEHYDROGENASE 1/2 (IDH1/2) MUTATION. (9th November 2020) Authors: Mellinghoff, Ingo; van den Bent, Martin; Clarke, Jennifer; Maher, Elizabeth; Peters, Katherine; Touat, Mehdi; de Groot, John; De La Fuente, Macarena; Arrillaga-Romany, Isabel; Wick, Wolfgang; Ellingson, Benjamin; Schoenfeld, Steven; Liu, Hua; Le, Kha; Lu, Min; Steelman, Lori; Hassan, Islam; Pandy... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. SPCR-03 NEUROCOGNITIVE OUTCOMES FROM PHASE 1 TRIAL OF BMX-001 IN COMBINATION WITH CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA PATIENTS. (5th August 2022) Authors: Peters, Katherine; Kirkpatrick, John; Batinic-Haberle, Ines; Affronti, Mary Lou; Woodring, Sarah; Lipp, Eric; Herndon, James; Boyd, Kendra; Spasojevic, Ivan; Penchev, Sara; Gad, Shayne; Silberstein, David; Johnson, Margaret; Desjardins, Annick; Friedman, Henry; Ashley, David; Crapo, James Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. TRLS-10. MITIGATING NEUROCOGNITIVE DEFICITS FROM WHOLE-BRAIN RADIOTHERAPY IN PATIENTS WITH NUMEROUS BRAIN METASTASES VIA A NOVEL SUPEROXIDE DISMUTASE MIMETIC: RATIONALE & DESIGN OF A CLINICAL TRIAL. (12th August 2019) Authors: Kirkpatrick, John; Franklin, Heather; Torok, Jordan; Floyd, Scott; Anders, Carey; Fecci, Peter; Salama, April; Clarke, Jeffrey; George, Daniel; Crapo, James; Peters, Katherine Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗